Page 32 | Certara

On-Demand Webinar

From Research to Real-World Impact: A Model Informed Drug Development (MIDD) Framework to Support Understudied Populations

SVP, Client and Regulatory Strategy, Certara Dr. Karen Rowland Yeo is Senior Vice-President, Client &…

CertaraJanuary 3, 2025

Press Release

Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

January 2, 2025 RADNOR, Pa. — January 2, 2025 — Certara, Inc. (Nasdaq: CERT), a global leader…

CertaraJanuary 2, 2025

Press Coverage

AI in Life Sciences Finds an Early Success and Will Continue in 2025

Fran Brown highlights how AI in life sciences drives more precise drug development and reduces…

CertaraDecember 24, 2024

Case Study

Streamlining the Preparation of 1-Year and 2-Year PSURs

We explore how we helped one client deliver a last-minute addition to a Periodic Safety…

CertaraDecember 18, 2024

Announcement

Certara Launches v12.0 of SEND Explorer

December 18, 2024 Radnor, PA – December 18, 2024 – Certara, Inc. (Nasdaq: CERT), a global leader in model-informed…

CertaraDecember 18, 2024

Blog

CMS Cell and Gene Therapy (CGT) Access Model Explained: The Most Significant Drug Pricing Legislation You’ve Never Heard Of

December 13, 2024 The Centers for Medicare & Medicaid Services (CMS) is piloting a program…

CertaraDecember 13, 2024

Poster

A Scalable Cloud Platform Accelerates QSP Virtual Patient Generation

CertaraDecember 13, 2024

Poster

Difference in efficacy between anti-PD-1 and anti-PD-L1 antibodies may be attributable to PD-1:PD-L2 complex inhibition, rather than differences in PD-1:PD-L1 inhibition

CertaraDecember 13, 2024

Poster

Cumulative drug binding to Cerebral Amyloid Angiopathy (CAA) predicts ARIA-E incidence for anti-Aβ antibodies in Alzheimer’s Disease

CertaraDecember 13, 2024

Poster

QSP model of neuroinflammation: Effect of TREM2 stimulation on microglial activation and function in the context of Alzheimer’s disease

CertaraDecember 13, 2024

© 2025 Certara. All Rights Reserved. | Legal | Privacy policy